Novel high–throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel high–throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors
Authors
Keywords
Fibroblasts, Cell differentiation, Tubulins, Library screening, Pulmonary fibrosis, Glycosides, SMAD signaling, Prostaglandin
Journal
PLoS One
Volume 13, Issue 11, Pages e0207872
Publisher
Public Library of Science (PLoS)
Online
2018-11-29
DOI
10.1371/journal.pone.0207872
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of myofibroblast differentiation by cardiac glycosides
- (2016) Jennifer La et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Reversal of the Transcriptome by Prostaglandin E2during Myofibroblast Dedifferentiation
- (2016) Scott H. Wettlaufer et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group
- (2016) C. M. Sköld et al. JOURNAL OF INTERNAL MEDICINE
- Discovery of G Protein-Biased EP2 Receptor Agonists
- (2016) Seiji Ogawa et al. ACS Medicinal Chemistry Letters
- A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis
- (2015) Yasmina Bauer et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
- (2015) Thomas Sander et al. Journal of Chemical Information and Modeling
- Halofuginone — The Multifaceted Molecule
- (2015) Mark Pines et al. MOLECULES
- Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2
- (2015) Amali P. Epa et al. PLoS One
- Reversal of myofibroblast differentiation: A review
- (2014) XiaoHong Yang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
- (2013) Timothy S. Blackwell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Reversal of Myofibroblast Differentiation by Prostaglandin E2
- (2013) Garth Garrison et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Reversible and irreversible differentiation of cardiac fibroblasts
- (2013) Ronald B. Driesen et al. CARDIOVASCULAR RESEARCH
- Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
- (2013) Jeong-Hwan Yoon et al. EMBO Molecular Medicine
- Effective myofibroblast dedifferentiation by concomitant inhibition of TGF-β signaling and perturbation of MAPK signaling
- (2013) Jan Kosla et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Sphingosine 1-Phosphate (S1P) Receptor Agonists Mediate Pro-fibrotic Responses in Normal Human Lung Fibroblasts via S1P2and S1P3Receptors and Smad-independent Signaling
- (2013) Katrin Sobel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent Developments in Myofibroblast Biology
- (2012) Boris Hinz et al. AMERICAN JOURNAL OF PATHOLOGY
- Nuclear Factor Erythroid 2-Related Factor 2 Nuclear Translocation Induces Myofibroblastic Dedifferentiation in Idiopathic Pulmonary Fibrosis
- (2012) Elise Artaud-Macari et al. ANTIOXIDANTS & REDOX SIGNALING
- Molecular analysis of the TGF-beta controlled gene expression program in chicken embryo dermal myofibroblasts
- (2012) Jan Kosla et al. GENE
- Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
- (2012) Paola Picotti et al. NATURE METHODS
- Prostaglandin E2 protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction
- (2011) Ryan T. Dackor et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Prostaglandin E2and the Pathogenesis of Pulmonary Fibrosis
- (2011) Paul D. Bozyk et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist
- (2011) KJ af Forselles et al. BRITISH JOURNAL OF PHARMACOLOGY
- Reversible differentiation of myofibroblasts by MyoD
- (2011) Louise Hecker et al. EXPERIMENTAL CELL RESEARCH
- TGF-β signaling in fibrosis
- (2011) Anna Biernacka et al. GROWTH FACTORS
- Integrating mechanisms of pulmonary fibrosis
- (2011) Thomas A. Wynn JOURNAL OF EXPERIMENTAL MEDICINE
- The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice
- (2010) Kristy A. Bauman et al. JOURNAL OF CLINICAL INVESTIGATION
- The Discovery of 4-{1-[({2,5-Dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic Acid (MK-2894), A Potent and Selective Prostaglandin E2Subtype 4 Receptor Antagonist†
- (2010) Marc Blouin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Requirement of transforming growth factor β-activated kinase 1 for transforming growth factor β-induced α-smooth muscle actin expression and extracellular matrix contraction in fibroblasts
- (2009) Xu Shi-Wen et al. ARTHRITIS AND RHEUMATISM
- Discovery of CP-533536: An EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation
- (2009) Kimberly O. Cameron et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Prostaglandin E2Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1
- (2008) Steven K. Huang et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- 16,16-Dimethyl Prostaglandin E2Efficacy on Prevention and Protection from Bleomycin-Induced Lung Injury and Fibrosis
- (2008) Marco Failla et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases
- (2008) Anna-Luise A. Katzenstein et al. HUMAN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More